The information provided by the AI-powered platform is expected to help individuals better understand how their lifestyle and behavior affect their glucose levels. The app translates these glucose ...

ORLANDO, FLORIDA / ACCESS Newswire / August 19, 2025 / RedChip Companies, an international investor relations, media, and ...

The FDA says it will use artificial intelligence to expedite the approval of new drugs and devices. Investigators with the ...

The Global Mass Spectrometry Market size valued at approximately USD 6.9 billion in 2024, is projected to reach USD 10.38 billion by 2030, growing at ...

Digital transformation in healthcare accelerates adoption of AI-enabled monitoring solutions across global marketsDelray ...

Signos announced today that it launched its FDA-cleared over-the-counter glucose monitoring system for weight management.

Walmart recalls shrimp in 13 states after FDA finds radioactive contamination. OpenAI challenger Manus hits $90M revenue run ...

Nerveblox, the ultrasound AI for regional anaesthesia receives US FDA 510(k) clearance: Ankara Wednesday, August 20, 2025, 15:00 Hrs [IST] Nerveblox, an AI software solution by Sm ...

There is an immediate need for a new, agile process that helps everyday people find safe and trustworthy mental health AI ...

In a significant development for weight management, the Food and Drug Administration (FDA) announced Wednesday its approval ...

The rally in the market came as the approval made PAPZIMEOS the first and only FDA-approved therapy for adult RRP patients.